SEC Form 4 · accession 0001209191-15-033985
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Discovery Medicinal and P
Period of report
Apr 10, 2015
Accepted (ET)
Apr 14, 2015 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2015 | M | 9,000 | $17.79 | A | 37,689 | D | |
| Common StockF1 | Apr 10, 2015 | S | 9,000 | $92.75 | D | 28,689 | D | |
| Common Stock | Apr 13, 2015 | M | 14,000 | $17.79 | A | 42,689 | D | |
| Common StockF1 | Apr 13, 2015 | S | 14,000 | $96.75 | D | 28,689 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.79 | Apr 10, 2015 | M | 9,000 | D | — | Jan 18, 2019 | Common Stock | 9,000 | 49,354 | D |
| Non-Qualified Stock Option (right to buy)F2 | $17.79 | Apr 13, 2015 | M | 14,000 | D | — | Jan 18, 2019 | Common Stock | 14,000 | 35,354 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.